China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SZSE:000999
Intrinsic Value
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the manufacture, development, and sale of pharmaceutical products. [ Read More ]
The intrinsic value of one
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
stock under the Base Case scenario is
67.6
CNY.
Compared to the current market price of 58.78 CNY,
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
is
Undervalued by 13%.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's market capitalization is 57.6B CNY.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd stock price is 58.78 CNY.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd stock price (58.78 CNY) is 13% less than its Intrinsic Value (67.6 CNY).
China Resources Sanjiu Medical & Pharmaceutical Co Ltd stock price (58.78 CNY) is 8% less than its DCF Value (64.1 CNY). Open DCF Valuation
China Resources Sanjiu Medical & Pharmaceutical Co Ltd stock price (58.78 CNY) is 17% less than its Relative Value (71.11 CNY). Open Relative Valuation
China Resources Sanjiu Medical & Pharmaceutical Co Ltd has upside potential of 14% compared to the average analyst price target.
Open Wall St Estimates
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 12%.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's ROIC (Return on Invested Capital) has increased in the last 3 years from 10% to 12%.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd has positive Net Income for the last twelve months.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's ROE (Return on Equity) has increased in the last 3 years from 12% to 16%.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 16%.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd has positive Operating Income for the last twelve months.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd has positive three-year average ROIC (Return on Invested Capital): 14%. The company is efficient at using invested capital to generate operating income.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's Revenue is forecast to grow at a rate of 11% per year over the next 3 years.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's Revenue has grown by an exceptional 37% over the past 12 months.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd has positive three-year average ROE (Return on Equity): 17%. The company is efficient at transforming stockholders' equity into net income.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd has positive Free Cash Flow for the last twelve months.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's short-term assets (23B CNY) exceed its short-term liabilties (13B CNY).
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's Revenue has been growing by an exceptional 22% per year for the last 3 years.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's Altman Z-Score is equal to 2.97.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's long-term assets (40B CNY) exceed its long-term liabilties (21B CNY).
China Resources Sanjiu Medical & Pharmaceutical Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (8B CNY) than debt (4B CNY).
China Resources Sanjiu Medical & Pharmaceutical Co Ltd has positive Gross Profit for the last twelve months.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.2.
Valuation Backtest
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
Run backtest to discover the historical profit from buying and selling
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
Balance Sheet Decomposition
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
| Current Assets | 22.5B |
| Cash & Short-Term Investments | 8.1B |
| Receivables | 8.6B |
| Other Current Assets | 5.9B |
| Non-Current Assets | 17.6B |
| Long-Term Investments | 715m |
| PP&E | 6.8B |
| Intangibles | 9.2B |
| Other Non-Current Assets | 894.3m |
| Current Liabilities | 12.9B |
| Accounts Payable | 2.4B |
| Accrued Liabilities | 1.6B |
| Short-Term Debt | 1.9B |
| Other Current Liabilities | 7.1B |
| Non-Current Liabilities | 8.2B |
| Long-Term Debt | 1.9B |
| Other Non-Current Liabilities | 6.3B |
Earnings Waterfall
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
|
Revenue
|
24.7B
CNY
|
|
Cost of Revenue
|
-11.7B
CNY
|
|
Gross Profit
|
13.1B
CNY
|
|
Operating Expenses
|
-9.3B
CNY
|
|
Operating Income
|
3.8B
CNY
|
|
Other Expenses
|
-947.6m
CNY
|
|
Net Income
|
2.9B
CNY
|
Free Cash Flow Analysis
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
Profitability Score
Profitability Due Diligence
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Score
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Score
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
is 66.81 CNY
with a low forecast of 55.55 CNY and a high forecast of 81.9 CNY.
Shareholder Return
Price
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
| Average Annual Return | 20.76% |
| Standard Deviation of Annual Returns | 31.21% |
| Max Drawdown | -39% |
| Market Capitalization | 57.6B CNY |
| Shares Outstanding | 988 184 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the manufacture, development, and sale of pharmaceutical products. The company is headquartered in Shenzhen, Guangdong and currently employs 15,420 full-time employees. The company went IPO on 2000-03-09. The firm's pharmaceutical products include over the counter (OTC) drugs and prescription drugs. The firm's drugs are used for the treatment in cold, gastroenterology, dermatology, pediatrics, cardiovascular and cerebrovascular diseases, anti-tumor, anti-infection, digestive system, orthopedics and other areas. The firm is also involved in packaging and printing and international trading businesses. The firm distributes its products in domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
stock under the Base Case scenario is
67.6
CNY.
Compared to the current market price of 58.78 CNY,
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
is
Undervalued by 13%.
You don't have any saved screeners yet
